Total Payments
$23,567
2024 Payments
$12,501
Companies
8
Transactions
126
Medicare Patients
855
Medicare Billing
$122,592
Payment Breakdown by Category
Other$19,556 (83.0%)
Food & Beverage$2,844 (12.1%)
Travel$1,167 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,556 | 7 | 83.0% |
| Food and Beverage | $2,844 | 118 | 12.1% |
| Travel and Lodging | $1,167 | 1 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $22,818 | 93 | $0 (2024) |
| Lundbeck LLC | $240.32 | 11 | $0 (2024) |
| PFIZER INC. | $198.18 | 10 | $0 (2024) |
| Allergan, Inc. | $122.66 | 2 | $0 (2020) |
| Lilly USA, LLC | $108.16 | 6 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $38.78 | 2 | $0 (2022) |
| Merz Pharmaceuticals, LLC | $22.99 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $17.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,501 | 67 | ABBVIE INC. ($12,244) |
| 2023 | $10,531 | 42 | AbbVie Inc. ($10,201) |
| 2022 | $334.66 | 14 | ABBVIE INC. ($295.88) |
| 2021 | $77.81 | 1 | AbbVie Inc. ($77.81) |
| 2020 | $17.50 | 1 | Allergan, Inc. ($17.50) |
| 2019 | $105.16 | 1 | Allergan Inc. ($105.16) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: PAIN | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.54 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: PAIN | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 84 | 5,123 | $69,877 | $36,125 |
| 2022 | 4 | 70 | 70 | $41,268 | $4,567 |
| 2021 | 12 | 316 | 512 | $342,090 | $39,410 |
| 2020 | 12 | 385 | 532 | $368,094 | $42,490 |
Total Patients
855
Total Services
6,237
Medicare Billing
$122,592
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 5,000 | $45,000 | $24,647 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 69 | $13,731 | $5,898 | 43.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $10,166 | $5,087 | 50.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 12 | 20 | $980.00 | $493.46 | 50.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $3,843 | $1,685 | 43.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 25 | $11,625 | $1,537 | 13.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 18 | 18 | $23,400 | $1,088 | 4.7% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Facility | 2022 | 16 | 16 | $2,400 | $256.25 | 10.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 108 | $46,980 | $7,572 | 16.1% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 25 | 76 | $94,240 | $6,629 | 7.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 28 | 33 | $76,560 | $4,924 | 6.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 38 | 49 | $30,380 | $4,708 | 15.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 30 | 30 | $24,000 | $4,151 | 17.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 23 | 23 | $18,170 | $3,558 | 19.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 38 | $12,540 | $1,999 | 15.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 22 | $9,900 | $1,677 | 16.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 28 | $8,260 | $1,469 | 17.8% |
| 98925 | Osteopathic manipulative treatment to 1-2 body regions | Facility | 2021 | 23 | 62 | $8,990 | $1,162 | 12.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 24 | 24 | $9,600 | $1,086 | 11.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 11 | 19 | $2,470 | $474.16 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 75 | 142 | $59,191 | $7,628 | 12.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 41 | 44 | $97,680 | $7,026 | 7.2% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2020 | 25 | 62 | $73,160 | $5,261 | 7.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 30 | 30 | $22,670 | $4,419 | 19.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 49 | $21,070 | $3,904 | 18.5% |
About Dr. Aaron Bubolz, D.O
Dr. Aaron Bubolz, D.O is a Neurology healthcare provider based in Green Bay, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1831486828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Bubolz, D.O has received a total of $23,567 in payments from pharmaceutical and medical device companies, with $12,501 received in 2024. These payments were reported across 126 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,556).
As a Medicare-enrolled provider, Bubolz has provided services to 855 Medicare beneficiaries, totaling 6,237 services with total Medicare billing of $122,592. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Green Bay, WI
- Active Since 06/29/2011
- Last Updated 11/29/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831486828
Products in Payments
- QULIPTA (Drug) $17,829
- UBRELVY (Drug) $4,677
- BOTOX (Biological) $329.83
- VYEPTI (Biological) $240.32
- NURTEC ODT (Drug) $158.02
- EMGALITY (Drug) $108.16
- BOTOX (Drug) $105.16
- COMIRNATY (Biological) $58.74
- Xeomin (Biological) $22.99
- PAXLOVID (Drug) $20.20
- AJOVY (Biological) $17.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Green Bay
Dr. Sany Khabbaz, Md, MD
Neurology — Payments: $33,873
Neurology $33,873
Dr. Wilson Cueva, M.d, M.D
Neurology — Payments: $6,559
Neurology $6,559
Heather Stanko, Md, MD
Neurology — Payments: $4,640
Neurology $4,640
Dr. David Kaufman, Md, MD
Neurology — Payments: $3,557
Neurology $3,557
Dr. Celeste Case, Md, MD
Neurology — Payments: $2,458
Neurology $2,458
M. Ziad Darkhabani, Md, MD
Neurology — Payments: $817.05
Neurology $817.05